Synthesis and anticonvulsant activity of some novel fused heterocyclic l,2,4-triazolo-[3,4-b]-l,3,4-thiadiazole derivatives

Acta Poloniae Pharmaceutica - Drug Research

Volumn 66, Issue 2, 2009, Pages 135-140

  Husain, Asif ^a   Naseer, Mohammad A ^a   Sarafroz, Mohammad ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Anticonvulsants; Lipophilicity; Neurotoxicity; Triazoles; Triazolothiadiazole

Indexed keywords

CARBAMAZEPINE; PHENYTOIN; THIADIAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; MOUSE; NEUROTOXICITY; NONHUMAN;

ANIMALS; ANTICONVULSANTS; CHROMATOGRAPHY, THIN LAYER; ELECTROSHOCK; INDICATORS AND REAGENTS; MAGNETIC RESONANCE SPECTROSCOPY; MICE; NEUROTOXICITY SYNDROMES; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; THIADIAZOLES; TRIAZOLES;

EID: 64849093027     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Loscher W.: Eur. J. Pharmacol. 1, 342 (1998).
2. Chen L., Sun X. Y., Chai K. Y.: Bioorg. Med. Chem. 15, 6775 (2007).
3. Kubota M., Sakakihora Y.: Brain Dev. 22, 230 (2000).
4. French J. A.: Epilepsia 40, 11 (1999).
5. Meador K. J.: J. Clin. Psychiatry 64, 132 (2003).
6. Kupferberg H. J,. Stables J. P.: in Challenge Epilepsy - New Antiepileptic Drugs. Stefan H., Kramer G., Mamoli B. Eds., p. 7, Blackwell Sciences, Berlinl998.
7. Schenone S., Brullo C, Bruno O., et al.: Bioorg. Med. Chem. 14, 1698 (2006).
8. Matysiak J.: Chem. Pharm. Bull. 54, 988 (2006).
9. Hui X. P., Zang C. H., Wang Q., Zhang Q.: Indian J. Chem. 41B, 2176 (2002).
10. Dogan H. N., Duran A., Rollas S., Sener G., Uysal M. K., Gulen, D.: Bioorg. Med. Chem. 10, 2893 (2002).
11. Walczak K., Gondela A., Suwinski J.: Eur. J. Med. Chem. 39, 849 (2004).
12. Zhang Z. Y., Sun X. W.: Heterocycles 48, 3 (1998).
13. Holla B. S., Rao B. S., Sarojini B. K., Akberali P. M., Kumari N. S.: Eur. J. Med. Chem. 41, 657 (2006).
14. Mathew V., Keshavayya J., Vaidya V. P.: Eur. J. Med. Chem. 41, 1048 (2006).
15. Jin J., Zhang L., Chen X., Zhang A., Zhang H.: Molecules 12, 297 (2007).
16. th ed., p. 695, Longman Group, U.K.1991.
17. Reid J.R., Heindel N.D.: J. Heterocycl. Chem. 13, 925, 1976.
18. Stables J. P., Kupferberg H. J.: National Institute of Neurological Disorders and Stroke. Anticonvulsant Screening Project Report. Chapter 16. www.ninds.nih.gov/ anticonvulsant-screening-project.htm.
19. th ed., Levy R. H., Mattson R. H., Meldrum B. S. Eds., p. 99, Raven Press, New York 1995.
20. Kucukgzuel I., Kucukgzuel S. G., Roller S., et al. : J. Med. Chem. 49, 1212 (2006).
21. Lien E. J., Liuo R. C. H., Shinoucla H. G.: J. Pharm. Sci. 68, 463 (1979).
22. Leo A., Weininger D., Weininger A.: CLOGP, CMR. Med. Chem. Project, Pomona College: Claremont, C.A. Release 4.20, Distributed by Daylight Chemical Information Systems (1992).
23. Farrar V. A., Grochowski J., Serda P., et al.: J. Med. Chem. 36, 3517(1993).